Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to assess the efficacy of Dexmedetomidine drug either used sublingually or intranasally in managing healthy children during dental treatment


Clinical Trial Description

Each child should fulfill the requirements of having a dental condition which needs treatment in two dental sessions, where each session should not exceed thirty minutes. At the first visit ,either sublingual or intranasal Dexmedetomidine will be used, while at the second visit the alternate route will be implemented in a cross-over design. At least one week interval between the two visits will be secured. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04237532
Study type Interventional
Source University of Alexandria
Contact
Status Completed
Phase Phase 2/Phase 3
Start date August 27, 2019
Completion date August 10, 2020

See also
  Status Clinical Trial Phase
Completed NCT04695509 - Sedation and Neuromediators Concentration N/A
Completed NCT01941888 - Propofol TCI Administered by Gastroenterologists During Endoscopy: a Randomized Double Blind Controlled Study Phase 4
Recruiting NCT04329585 - GABA Antagonist to Improve Reversal of Anesthesia With High-density EEG Surveillance N/A
Completed NCT00834730 - Comparison of N2O Inhalation and Ketamine in Pediatric PSA Phase 4
Recruiting NCT04055077 - Influence of HFNO on Spontaneous Ventilation in Patients of Different ASA Risk During Analgo-sedation for Vitrectomy N/A
Completed NCT02708212 - Optimal Procedural Sequence in Same-day Bidirectional Endoscopy: A Prospective Randomized Controlled Study N/A